Turk Ilac ve Serum Sanayi AS Capital Reinvestment Ratio
Turk Ilac ve Serum Sanayi AS capital reinvestment ratio. Turk Ilac ve Serum Sanayi AS (TRILC) has a Capital Reinvestment Ratio of 3.20x as of September 2025, meaning it reinvests 3% of its operating cash flow (TL44.50 Million) in capital expenditures (TL142.42 Million). Check Turk Ilac ve Serum Sanayi AS (TRILC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Turk Ilac ve Serum Sanayi AS (2019–2023)
Capital reinvestment ratio of Turk Ilac ve Serum Sanayi AS from 2019 to 2023. This chart tracks Turk Ilac ve Serum Sanayi AS's Capital Reinvestment Ratio across 3 annual periods. Also explore Turk Ilac ve Serum Sanayi AS net asset momentum to track the company's year-over-year net asset growth rate.
Turk Ilac ve Serum Sanayi AS Capital Reinvestment Ratio by Year (2019–2023)
Turk Ilac ve Serum Sanayi AS capital reinvestment ratio by year from 2019 to 2023. For the full cash flow conversion analysis, see Turk Ilac ve Serum Sanayi AS operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.28x | TL408.19 Million | TL115.31 Million | ▼ -43.3% |
| 2020 | 0.50x | TL33.20 Million | TL16.54 Million | ▼ -73.4% |
| 2019 | 1.87x | TL13.32 Million | TL24.92 Million | — |